Scientific reporting is suboptimal for aspects that characterize genetic risk prediction studies: a review of published articles based on the Genetic RIsk Prediction Studies statement.

[1]  J. Achten,et al.  A systematic survey of the quality of research reporting in general orthopaedic journals. , 2011, The Journal of bone and joint surgery. British volume.

[2]  C. Hudis,et al.  Discriminatory accuracy and potential clinical utility of genomic profiling for breast cancer risk in BRCA-negative women , 2011, Breast Cancer Research and Treatment.

[3]  R. Morris,et al.  The quality of reporting of primary test accuracy studies in obstetrics and gynaecology: application of the STARD criteria , 2011, BMC women's health.

[4]  Siobhan M. Dolan,et al.  Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration , 2011, European Journal of Epidemiology.

[5]  J. Ioannidis,et al.  Strengthening the reporting of genetic risk prediction studies: the GRIPS statement , 2011, European Journal of Human Genetics.

[6]  Fredrik Wiklund,et al.  Inherited genetic markers discovered to date are able to identify a significant number of men at considerably elevated risk for prostate cancer , 2011, The Prostate.

[7]  N. Pouratian,et al.  Standards for reporting randomized controlled trials in neurosurgery. , 2011, Journal of neurosurgery.

[8]  Jianxin Shi,et al.  Genetic risk sum score comprised of common polygenic variation is associated with body mass index , 2011, Human Genetics.

[9]  M. Laakso,et al.  Impact of Positive Family History and Genetic Risk Variants on the Incidence of Diabetes , 2011, Diabetes Care.

[10]  R. Chettier,et al.  Validation of DNA-Based Prognostic Testing to Predict Spinal Curve Progression in Adolescent Idiopathic Scoliosis , 2010, Spine.

[11]  David A. Hinds,et al.  Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical Information , 2010, Journal of the National Cancer Institute.

[12]  Stephen T. C. Wong,et al.  Using genetic and clinical factors to predict tacrolimus dose in renal transplant recipients. , 2010, Pharmacogenomics.

[13]  C. Wijmenga,et al.  Exploring genetic determinants of plasma total cholesterol levels and their predictive value in a longitudinal study. , 2010, Atherosclerosis.

[14]  A. Telenti,et al.  Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  S. Knuutila,et al.  Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data. , 2010, Leukemia research.

[16]  B. Psaty,et al.  Genetic predictors of medically refractory ulcerative colitis , 2010, Inflammatory bowel diseases.

[17]  L. Peltonen,et al.  A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses , 2010, The Lancet.

[18]  Richard W. Grant,et al.  Genetic Risk Reclassification for Type 2 Diabetes by Age Below or Above 50 Years Using 40 Type 2 Diabetes Risk Single Nucleotide Polymorphisms , 2010, Diabetes Care.

[19]  Toshihiro Tanaka,et al.  Prediction model for knee osteoarthritis based on genetic and clinical information , 2010, Arthritis Research & Therapy.

[20]  S. Hazen,et al.  Improved Prediction of Cardiovascular Disease Based on a Panel of Single Nucleotide Polymorphisms Identified Through Genome-Wide Association Studies , 2010, Circulation. Cardiovascular genetics.

[21]  F. Hu,et al.  Genetic Predisposition to Long-Term Nondiabetic Deteriorations in Glucose Homeostasis , 2010, Diabetes.

[22]  C. Gieger,et al.  Common Variants at 10 Genomic Loci Influence Hemoglobin A1C Levels via Glycemic and Nonglycemic Pathways , 2010, Diabetes.

[23]  N. Pandis,et al.  An assessment of quality characteristics of randomised control trials published in dental journals. , 2010, Journal of dentistry.

[24]  Tero Aittokallio,et al.  Genetic Variants and Their Interactions in the Prediction of Increased Pre-Clinical Carotid Atherosclerosis: The Cardiovascular Risk in Young Finns Study , 2010, PLoS genetics.

[25]  M. Laakso,et al.  Identification of undiagnosed type 2 diabetic individuals by the finnish diabetes risk score and biochemical and genetic markers: a population-based study of 7232 Finnish men. , 2010, The Journal of clinical endocrinology and metabolism.

[26]  B. Horne,et al.  Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease. , 2010, American heart journal.

[27]  A. Uitterlinden,et al.  Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease. , 2010, European heart journal.

[28]  W. Catalona,et al.  Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk. , 2010, The Journal of urology.

[29]  F. Collins,et al.  The path to personalized medicine. , 2010, The New England journal of medicine.

[30]  A. Doney,et al.  Combined Effect of Inflammatory Gene Polymorphisms and the Risk of Ischemic Stroke in a Prospective Cohort of Subjects With Type 2 Diabetes: A Go-DARTS Study , 2010, Diabetes.

[31]  Wei Lu,et al.  Genetic and clinical predictors for breast cancer risk assessment and stratification among Chinese women. , 2010, Journal of the National Cancer Institute.

[32]  P. Franks,et al.  Evaluating the discriminative power of multi-trait genetic risk scores for type 2 diabetes in a northern Swedish population , 2010, Diabetologia.

[33]  F. Hu,et al.  Combined effects of 17 common genetic variants on type 2 diabetes risk in a Han Chinese population , 2010, Diabetologia.

[34]  W. Siegert,et al.  Impact of genomic risk factors on outcome after hematopoietic stem cell transplantation for patients with chronic myeloid leukemia , 2010, Haematologica.

[35]  Sudha Seshadri,et al.  Genome-wide analysis of genetic loci associated with Alzheimer disease. , 2010, JAMA.

[36]  T. Huizinga,et al.  Genetic variants in the prediction of rheumatoid arthritis , 2010, Annals of the rheumatic diseases.

[37]  H. Williams,et al.  The reporting of observational research studies in dermatology journals: a literature-based study. , 2010, Archives of dermatology.

[38]  Sally Hopewell,et al.  The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed , 2010, BMJ : British Medical Journal.

[39]  M. Thun,et al.  Performance of common genetic variants in breast-cancer risk models. , 2010, The New England journal of medicine.

[40]  P. Kraft,et al.  Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk , 2010, Annals of the rheumatic diseases.

[41]  J. Huyghe,et al.  Evaluation of host genetic and viral factors as surrogate markers for HTLV‐1‐associated myelopathy/tropical spastic paraparesis in Peruvian HTLV‐1‐infected patients , 2010, Journal of medical virology.

[42]  A. Lucia,et al.  Can we identify a power-oriented polygenic profile? , 2010, Journal of applied physiology.

[43]  G. Dawson,et al.  Assessing the impact of a combined analysis of four common low-risk genetic variants on autism risk , 2010, Molecular autism.

[44]  Nancy R Cook,et al.  Association between a literature-based genetic risk score and cardiovascular events in women. , 2010, JAMA.

[45]  F. Holsboer,et al.  Polymorphisms in GRIK4, HTR2A, and FKBP5 Show Interactive Effects in Predicting Remission to Antidepressant Treatment , 2010, Neuropsychopharmacology.

[46]  S. Humphries,et al.  Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study , 2010, BMJ : British Medical Journal.

[47]  C. Bouchard,et al.  Combining genetic markers and clinical risk factors improves the risk assessment of impaired glucose metabolism , 2010, Annals of medicine.

[48]  D. Moher,et al.  A catalogue of reporting guidelines for health research , 2010, European journal of clinical investigation.

[49]  W. Sauerbrei,et al.  Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines , 2009, British Journal of Cancer.

[50]  S. Levy,et al.  An agenda for personalized medicine , 2009, Nature.

[51]  M. Gratacós,et al.  Nucleotide variation in central nervous system genes among male suicide attempters , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[52]  P. Masand,et al.  The impact of the CONSORT statement on reporting of randomized clinical trials in psychiatry. , 2009, Contemporary clinical trials.

[53]  A. Janssens,et al.  Genome-based prediction of common diseases: methodological considerations for future research , 2009, Genome Medicine.

[54]  J. Ioannidis,et al.  STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement , 2009, Annals of Internal Medicine.

[55]  L. Thabane,et al.  Quality of reporting of randomized controlled trials in general endocrinology literature. , 2008, The Journal of clinical endocrinology and metabolism.

[56]  N. Wilczynski.  Quality of reporting of diagnostic accuracy studies: no change since STARD statement publication--before-and-after study. , 2008, Radiology.

[57]  R. Agha,et al.  The reporting quality of randomised controlled trials in surgery: a systematic review. , 2007, International journal of surgery.

[58]  E. Elm,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[59]  P. Bossuyt,et al.  Quality of reporting of test accuracy studies in reproductive medicine: impact of the Standards for Reporting of Diagnostic Accuracy (STARD) initiative. , 2006, Fertility and sterility.

[60]  Diana Elbourne,et al.  Standards of Reporting of Randomized Controlled Trials in General Surgery: Can We Do Better? , 2006, Annals of surgery.

[61]  P. Bossuyt,et al.  The quality of diagnostic accuracy studies since the STARD statement , 2006, Neurology.

[62]  Francis S Collins,et al.  Realizing the promise of genomics in biomedical research. , 2005, JAMA.

[63]  for the Statistics Subcommittee of the NCI—EORTC Worki Diagnostics.  REporting recommendations for tumor MARKer prognostic studies (REMARK) , 2005, Nature Clinical Practice Oncology.

[64]  A. Azuara-Blanco,et al.  The quality of reporting of diagnostic accuracy studies published in ophthalmic journals , 2005, British Journal of Ophthalmology.

[65]  C. Gatsonis,et al.  Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative , 2003, BMJ : British Medical Journal.

[66]  D. Moher,et al.  Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. , 2001, JAMA.

[67]  Y. Crow,et al.  Further delineation of the phenotype of severe congenital neutropenia type 4 due to mutations in G6PC3 , 2011, European Journal of Human Genetics.

[68]  Laura A. Hecker,et al.  Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. , 2010, Human molecular genetics.

[69]  E. Zintzaras,et al.  Assessing the quality of reporting of observational studies in cancer. , 2010, Annals of epidemiology.

[70]  R. Bausell,et al.  Quality of reporting randomized controlled trials (RCTs) in the nursing literature: application of the consolidated standards of reporting trials (CONSORT). , 2008, Nursing outlook.